PATEL JEEGAR PRAVINKUMAR (Chief Scientific Officer) sold 26.4% of their position (16.69K shares) of EVOMMUNE, INC. on the open market
Open‑market sale worth $379.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2026ACC: 0002092017-26-000005
Officer· Chief Scientific Officer
Since Nov 2025
-16.69K
Net shares
Net seller
$379.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.51K acquired · 30.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.51K
Price / share
$3.84
Trade value
$51.89K
% of position
27.3%
6/1/2026
49.58K→63.09K
Common Stock
Direct
Shares
−16.69K
Price / share
$22.74
Trade value
$379.46K
% of position
26.4%
6/1/2026
63.09K→46.40K
Total
Net shares
−3.17K
Net value
-$327.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +13.51K | $3.84 | $51.89K | 27.3% | 49.58K | 63.09K |
| Common Stock Direct | 6/1/2026 | S · Sale | −16.69K | $22.74 | $379.46K | 26.4% | 63.09K | 46.40K |
| Total | −3.17K | -$327.58K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
13.51K shares
Shares
−13.51K
Strike price
3.84
Held after
29.33K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock13.51K shares | 6/1/2026 | M · Option Exercise | −13.51K | 3.84 | — | 29.33K |